ORBIS' Matt Marchetti outlines how pharma companies can define supply chain impact, KPIs, and ROI when transitioning to reusable plastic pallets.
Matt Marchetti
Advertisement
Matt Marchetti is a strategic account manager with ORBIS Corporation.
Articles by Matt Marchetti
By prioritizing solutions such as reusable plastic pallets, pharmaceutical companies can ensure that their high-value innovations are protected by equally innovative packaging.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
What Germany's Drug Rebate Hike Means for US Pharma
2
The New Era of Pharma Distribution: Balancing Precision and Scale
3
Q&A: What Will It Take to Reshore US Drug Manufacturing?
4
Defining Supply Chain Impact When Transitioning to Reusable Packaging
5